ATARA BIOTHERAPEUTICS, INC. Research and Development in Process
ATARA BIOTHERAPEUTICS, INC. (ATRA) reported Research and Development in Process of $4.50 million for the 9-month period ending 2015-09-30, per its 10-Q filed 2015-11-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentInProcess · last filed 2015-11-06
- ATARA BIOTHERAPEUTICS, INC. research and development in process for the quarter ending 2015-09-30 was $0.00.
- ATARA BIOTHERAPEUTICS, INC. research and development in process for the quarter ending 2015-06-30 was $4.50M.
| Period end | Research and Development in Process 3 month | Research and Development in Process 4 month | Research and Development in Process 6 month | Research and Development in Process 9 month |
|---|---|---|---|---|
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $4.50M derived: sum of 2 quarters · filed 2015-11-06 | $4.50M 10-Q · filed 2015-11-06 | |
| 2015-06-30 | $4.50M 10-Q · filed 2015-08-07 | $4.50M 10-Q · filed 2015-08-07 | ||
| 2012-12-31 | $3.02M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| Vaxart, Inc. (VXRT) | United States | $0.080B | 3.84 |
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| Black Diamond Therapeutics, Inc. (BDTX) | United States | $0.109B | -2.48 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |